Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
CDIOW
CARDIO DIAGNOSTICS HOLDINGS, INC.
NASDAQ
$0.01
▲ UP 2.97% (0.00)

KEY STATISTICS

Market Cap$2.73 M
52w High$0.02
52w Low$0.01
Dividend Yield—
Frequency—
P/E—
Volume5.62K
Shares Out.2.07M

COMPANY

LEADERSHIP

Meeshanthini V. Dogan
CHIEF EXECUTIVE
Meeshanthini V. Dogan

ABOUT

SECTOR
Healthcare
WENT PUBLIC
January 14, 2022
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
15

UPCOMING EARNINGS

DateDec 2, 2026
DayWednesday
Rev. Est.—
DEC
2
WED

PRICE

$0.01 ▲ UP 2.97% (+$0.00)
$0.01$0.01$0.01$0.01$0.01$0.01$0.0110:54 AM11:11 AM11:28 AM11:46 AM12:03 PM12:20 PM12:37 PM0.01

About Cardio Diagnostics Holdings, Inc.

https://www.cdio.ai ↗

Cardio Diagnostics Holdings, Inc., founded in 2017 in Chicago, develops epigenetics-based clinical tests like Epi+Gen CHD to assess three-year coronary heart disease risk.

INDUSTRY

Biotechnology

A PRODUCT CARDIO DIAGNOSTICS HOLDINGS, INC. IS KNOWN FOR

PrecisionCHD
PrecisionCHD

PrecisionCHD is an AI-driven blood test for early, personalized detection of coronary heart disease, with recent international expansion highlighting its role in precision cardiovascular medicine.

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book5
Overall Score3

INSIDER TRADES

★
DIRECTOR
Betts Wendy J
Purchase · 2.9K shares
2026-06-30
★
DIRECTOR
Fung Peter K
Purchase · 2.9K shares
2026-06-30
★
DIRECTOR
Burton Paul Frederick
Purchase · 2.9K shares
2026-06-30
★
DIRECTOR
Intrater James
Purchase · 2.9K shares
2026-06-30

SECTORS PEERS

PEERPRICE
OABIW$0.28COMPARE
TVGN$5.88COMPARE
KPRX$2.58COMPARE
BCDA$0.95COMPARE
INAB$0.96COMPARE
CDIO$2.02COMPARE
APVO$4.12COMPARE
APRE$0.66COMPARE